Pityriasis Rosea: What to Do When Symptomatic Pruritus Treatment Has Not Worked
In pityriasis rosea, an initial strategy of watchful waiting with symptomatic pruritus management is standard first-line care. When that approach does not achieve adequate pruritus control, escalation to an active next-line treatment is indicated.
Previous treatment — goal not reached
Watchful waiting with symptomatic treatment of pruritus — using oral antihistamines or topical or oral corticosteroids — was the first approach taken. The target goal of control of pruritus was not met. This unmet goal is the trigger for the next treatment line described here.
Next-line approach
The next step involves an antiviral agent taken orally. The clinical goals are improvement in symptoms and resolution of skin lesions.
The full regimen — including agent, dosing options, course duration, and evidence grading — is available in the complete structured protocol below.
References
- Acyclovir is effective in the treatment of pityriasis rosea and may be considered in severe cases.
- Those who took acyclovir, 800 mg five times per day for seven days, had significant improvements in symptoms and lesion resolution.
- Lower doses (400 mg three to five times per day for seven days) also were effective in small randomized controlled trials that followed patients for up to four weeks.
View source ↗